Stopping Bipolar Medication: What Happens When You Quit and How to Do It Safely

If you’ve thought about stopping your bipolar medication, you’re not alone — and you’re not being irresponsible for having that thought.

Research consistently shows that between 20% and 60% of people with bipolar disorder are nonadherent to their medications at any given time, with an average of about 40%. The reasons are real: side effects that make daily life harder, the feeling of being stable enough to not need it anymore, medications that don’t fit into a life that moves and changes. These aren’t failures of character — they’re rational responses to a difficult reality.

This article won’t tell you that stopping your medication is always wrong. It will tell you what the research actually says about what happens when you do — and why the how matters enormously. If you’re considering stopping, the goal here is to give you the clearest picture possible so you can make that conversation with your provider as informed and productive as it can be.

If you’re looking for a care team that will actually listen to that conversation — rather than dismiss it — explore bipolar-specialized care at Sway Health.

Why People Stop Taking Bipolar Medications

Before getting to outcomes, it’s worth naming the reasons clearly — because they matter for what comes next.

A study examining attitudes toward bipolar medication found that the strongest predictor of stopping was a belief that the medication is simply unnecessary. This was followed by no perceived daily benefit, concern about changes in appearance (often weight-related), and a sense that medication interferes with life goals. These aren’t irrational positions. They’re what happens when the connection between the medication and stability isn’t felt or visible — especially during a period when things seem okay.

The other major reasons include:

• Side effects: Weight gain, cognitive dulling, tremors, fatigue, and sexual side effects are among the most commonly cited. Research reviewing nonadherence in bipolar disorder identified weight gain as the side effect most likely to impact medication adherence.
• Feeling well: Paradoxically, feeling stable — which the medication helped create — is one of the most common triggers for stopping it. Stability can feel like evidence that you no longer need it.
• Stigma: Taking psychiatric medication daily carries social and psychological weight that the clinical literature often underestimates.
• Cost and access: For many people, the financial burden of ongoing prescriptions is a real barrier.

Understanding why you want to stop is the first step toward a productive conversation about whether and how it might be safely approached. For more on what makes why bipolar medication adherence is so difficult, that context matters here too.

What Happens When You Stop Abruptly

This is where the research is clearest and most sobering.

Abrupt discontinuation — stopping your medication in a matter of days — significantly increases your risk of relapse, and it increases it quickly.

One of the most cited studies on lithium discontinuation tracked 32 patients who stopped lithium after at least five years of successful treatment: 62% relapsed within the first year, 32% within the first month, and 7% within the first week. Even among those who had been stable for years, the protection didn’t hold long after stopping.

Beyond basic relapse risk, there’s a specific phenomenon called rebound mania — a surge in manic symptoms that goes beyond what would have been expected based on the untreated course of illness. This rebound effect is particularly associated with lithium, and it’s distinct from a simple “return of illness.” One major review of bipolar medication nonadherence confirmed that abrupt lithium cessation specifically may cause rebound depression and mania — and that the median time to first lithium discontinuation in real-world settings is only 76 days, which means many people are stopping long before they see whether the medication was working.

It’s also worth noting what happened at the hospital level: a mirror-image study found that psychiatric hospital admissions and days in hospital per patient doubled within two years of stopping lithium. That’s the clinical cost of unmanaged discontinuation in the data.

The Difference Between Gradual and Abrupt: Why Tapering Matters

The research here is striking.

A pooled analysis of 161 patients with bipolar disorder compared gradual tapering (15-30 days) versus abrupt discontinuation (1-14 days) of lithium. The result: after gradual versus rapid discontinuation, the median time to recurrence differed by 5-fold — 20 months versus 4 months. Patients who stopped gradually remained stable off lithium 20 times more frequently than those who stopped abruptly.

This is not a minor difference. It suggests that how you stop matters almost as much as whether you stop.

Tapering — discontinuation, or “coming off,” — means reducing the dose slowly over weeks to months rather than stopping suddenly. The specific tapering schedule depends on:

• Which medication you’re taking (lithium, lamotrigine, valproate, and quetiapine all have different discontinuation considerations)
• How long you’ve been on it
• Your episode history and relapse risk
• Whether you’re switching to a different medication

This is precisely why tapering should always happen with your prescriber’s involvement — the protocol should be built around your specific situation, not a generic schedule.

Withdrawal Symptoms vs. Illness Relapse

One of the most practically important distinctions most content on this topic misses: stopping bipolar medication can cause withdrawal symptoms that look a lot like the beginning of an episode — but aren’t the same thing.

A comprehensive review of psychotropic medication discontinuation found that lithium withdrawal in particular is associated with anxiety, irritability, and sleep disturbances. These symptoms can appear within days of reducing or stopping.

Why this matters: If you stop medication and start feeling anxious and irritable, you might interpret that as early relapse — and in some cases it is. But in others, it’s a withdrawal response that would resolve on its own if managed carefully. Misreading a withdrawal response as relapse can lead to decisions (like restarting abruptly, or switching medications) that aren’t clinically necessary. Misreading early relapse as withdrawal can lead to not getting help quickly enough.

This is another reason this process shouldn’t happen without medical guidance. Distinguishing between these two phenomena in real time is a clinical judgment call.

When Discontinuation Might Be Appropriate

Most clinical guidelines for bipolar disorder — particularly bipolar I with multiple episodes — support the concept of lifelong maintenance pharmacotherapy. For most people with a documented pattern of episodes, the evidence strongly favors staying on medication.

That said, the picture isn’t entirely black and white. The Depression and Bipolar Support Alliance acknowledges that with careful planning, some people may be able to decrease or possibly discontinue medication — though mood symptoms can return even after months or years of stability.

Situations where a clinical conversation about discontinuation is most reasonable to have:

• After extended stability (typically 2+ years without an episode on medication)
• If you’re experiencing side effects that significantly affect quality of life and haven’t resolved with dose adjustment or medication switching
• If you’re planning a pregnancy and need to weigh fetal risk against relapse risk with your provider
• If your original diagnosis is uncertain and you and your provider want to assess the picture differently

In these cases, shared decision-making — the process of working through a decision with your provider that respects your values and autonomy while accounting for the clinical evidence — is the framework most guidelines recommend. This is not a conversation that should be one-sided.

What the Conversation with Your Provider Should Actually Look Like

Most articles on this topic end with “talk to your doctor.” That’s true — but it’s not enough.

Here’s what a productive conversation about stopping bipolar medication can include:

• Why you want to stop: Be specific. Side effects? Feeling stable? Cost? The answer shapes the response. If it’s side effects, there may be a lower-risk option. If it’s feeling stable, there’s clinical data worth walking through together.
• What tapering would look like: Ask for a specific schedule, not a vague “we’ll slow down.” Get clarity on the timeline and what you’ll monitor.
• What to watch for: What are the early warning signs of relapse for you specifically? What should prompt you to contact the practice?
• What happens if you relapse: If an episode occurs after discontinuing, what’s the plan? Having this mapped out in advance reduces the chaos if it happens.

About half of people with bipolar disorder become nonadherent at some point during long-term treatment — which means this conversation is common, and any provider who dismisses it without engaging is missing an opportunity to keep you in care.

For more on building a resilient approach to long-term stability, see relapse prevention strategies for bipolar disorder.

The Alternative Path: Addressing Why You Want to Stop

Sometimes “I want to stop” is actually “I want this medication to work better.” These aren’t the same question — and conflating them leads to stopping when a switch or adjustment might have resolved the issue.

If side effects are driving the impulse to stop, options worth exploring include:

• Dose adjustment: Sometimes the therapeutic level and the side-effect-minimizing level can be aligned better
• Medication switch: If lithium is causing weight gain or tremors, other mood stabilizers (lamotrigine, for example) have different side effect profiles. Understanding how mood stabilizers work differently from each other is useful context here.
• Adjunctive approach: Addressing a specific side effect (like metabolic effects) with a targeted intervention rather than stopping the primary medication
• Precision prescribing: A bipolar-specialized provider may think about your medication algorithm differently than a general psychiatrist — with more attention to which agent fits your specific symptom pattern, episode history, and tolerability

The goal, always, is a medication plan you can actually stay on — because research confirms that instability in adherence is itself a risk factor for worse long-term outcomes.

The Bottom Line

Stopping bipolar medication is a decision that deserves the same clinical weight as starting it. The research is clear that abrupt discontinuation carries significant risk — particularly for mania — and that gradual tapering dramatically reduces that risk. It’s also clear that the reasons people want to stop are legitimate, and that the best clinical response is engagement, not dismissal.

If you’re at a place where stopping feels like the only option, that’s often a signal that something about your current care isn’t working — which is a solvable problem, not a permanent one. A second opinion from a bipolar-specialized provider is often where that path begins.

If this sounds like where you are, see a bipolar disorder specialist online at Sway Health — a low-commitment way to see what a different approach to your medication might look like.